NasdaqGS - Nasdaq Real Time Price USD
IGM Biosciences, Inc. (IGMS)
1.1300
0.0000
(0.00%)
At close: May 9 at 4:00:02 PM EDT
1.1100
-0.02
(-1.77%)
After hours: May 9 at 7:47:58 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.45 | -0.36 | -1.44 | -0.49 |
| Low Estimate | -0.45 | -0.36 | -1.48 | -0.75 |
| High Estimate | -0.45 | -0.36 | -1.4 | -0.23 |
| Year Ago EPS | -0.83 | -0.79 | -3.24 | -1.44 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 4 |
| Avg. Estimate | 4.25M | 4.25M | 9.76M | 6.82M |
| Low Estimate | 2.5M | 2.5M | 2M | -- |
| High Estimate | 6M | 6M | 24.02M | 20M |
| Year Ago Sales | 497k | 1.25M | 2.68M | 9.76M |
| Sales Growth (year/est) | 755.63% | 239.11% | 264.13% | -30.06% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.85 | -0.04 | -0.8 | -0.71 |
| EPS Actual | -0.83 | -0.79 | -1.01 | -0.61 |
| Difference | 0.02 | -0.75 | -0.21 | 0.1 |
| Surprise % | 2.35% | -1,978.95% | -26.71% | 14.15% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.45 | -0.36 | -1.44 | -0.49 |
| 7 Days Ago | -0.49 | -0.28 | -1.48 | -0.69 |
| 30 Days Ago | -0.55 | -0.22 | -1.48 | -0.72 |
| 60 Days Ago | -0.62 | -0.38 | -1.13 | -0.72 |
| 90 Days Ago | -0.66 | -0.58 | -2.32 | -1.79 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | 1 |
| Down Last 7 Days | -- | 1 | -- | 1 |
| Down Last 30 Days | -- | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IGMS | 45.78% | 54.43% | 55.56% | 65.97% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Upgrade | JP Morgan: Underweight to Neutral | 1/13/2025 |
| Downgrade | Jefferies: Buy to Hold | 1/10/2025 |
| Maintains | Truist Securities: Hold to Hold | 1/10/2025 |
| Downgrade | Stifel: Buy to Hold | 1/10/2025 |
| Downgrade | RBC Capital: Outperform to Sector Perform | 1/10/2025 |
| Downgrade | BMO Capital: Outperform to Market Perform | 1/10/2025 |
Related Tickers
MGNX MacroGenics, Inc.
1.4300
-7.14%
MRSN Mersana Therapeutics, Inc.
0.3189
-4.81%
XNCR Xencor, Inc.
8.33
-5.23%
ALXO ALX Oncology Holdings Inc.
0.4223
-8.24%
RLYB Rallybio Corporation
0.2930
0.00%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2300
-2.38%
PLRX Pliant Therapeutics, Inc.
1.4100
-3.42%
APGE Apogee Therapeutics, Inc.
37.29
-1.38%
KROS Keros Therapeutics, Inc.
13.64
-2.70%
ARTV Artiva Biotherapeutics, Inc.
2.0800
-4.59%